12/12/2006

A new study indicates a combination treatment using pentostatin, cyclophosphamide and rituximab helps manage chronic lymphocytic leukemia. About 10,000 people in the U.S. are diagnosed each year with the incurable blood and bone marrow cancer.

Full Story:
Forbes

Related Summaries